drugset / Trial / NCT01443208
Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet
RandomizedParallel-groupTriple-blindBasic science
Summary
To evaluate the pharmacokinetics and safety of single dose and multiple doses of desvenlafaxine in Korean healthy subjects and compare to westerners.
Timeline
- Start
- 2011-11
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | Oral |
| Subject | Desvenlafaxine | Other / unclassified | 100 mg | Oral |
| Subject | Desvenlafaxine | Other / unclassified | 200 mg | Oral |